The Boehringer Ingelheim Foundation – Startup Investor Profile

The Boehringer Ingelheim Foundation is committed to advancing medical, biological, chemical, and pharmaceutical sciences.

Location: Mainz

Country:

Investment Regions: EU

Investment Stages: late-stage, pre-seed, seed, series-a

Website: https://boehringer-ingelheim-stiftung.de/en/

AI Reasoning: I found multiple press releases showing the foundation provided funding as recently as 22 July 2025 (EMBL imaging commitment) and major grants in 2024 (BioAI Dresden, AITHYRA in Vienna). Calculating from that most recent investment on 22 July 2025 to the evaluation reference date results in a gap exceeding 3 months but less than 12 months; however, classification thresholds require: very-active (12 months). The last investment was more than 12 months prior to the evaluation reference date, therefore classify as not-active. The 27 November 2024 investment to BioAI Dresden (EUR 20 million) and the Vienna AITHYRA (September 2024) were earlier; the startup/institution invested includes BioAI Dresden and AITHYRA (OeAW).

Not Active – No known investments in the last 12 months.

Low Activity – Only known investments between the last 12 and 6 months.

Active – Known investments between the last 6 and 3 months.

Very Active – Known investments in the last 3 months.